These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38950717)
81. Functionalized docetaxel-loaded lipid-based-nanosuspensions to enhance antitumor efficacy in vivo. Pang X; Wang T; Jiang D; Mu W; Zhang B; Zhang N Int J Nanomedicine; 2019; 14():2543-2555. PubMed ID: 31114190 [No Abstract] [Full Text] [Related]
82. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats. Thirupathi G; Swetha E; Narendar D Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936 [TBL] [Abstract][Full Text] [Related]
83. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691 [TBL] [Abstract][Full Text] [Related]
84. Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system. Pandey P; Chellappan DK; Tambuwala MM; Bakshi HA; Dua K; Dureja H Int J Biol Macromol; 2019 Dec; 141():596-610. PubMed ID: 31494160 [TBL] [Abstract][Full Text] [Related]
85. Preparation and investigation of indirubin-loaded SLN nanoparticles and their anti-cancer effects on human glioblastoma U87MG cells. Rahiminejad A; Dinarvand R; Johari B; Nodooshan SJ; Rashti A; Rismani E; Mahdaviani P; Saltanatpour Z; Rahiminejad S; Raigani M; Khosravani M Cell Biol Int; 2019 Jan; 43(1):2-11. PubMed ID: 30080277 [TBL] [Abstract][Full Text] [Related]
86. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation. Dudhipala N; Veerabrahma K Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472 [TBL] [Abstract][Full Text] [Related]
87. Phyllanthi Tannin Loaded Solid Lipid Nanoparticles for Lung Cancer Therapy: Preparation, Characterization, Pharmacodynamics and Safety Evaluation. Wang B; Wu K; Liu R; Huang Y; Chang Z; Gao Y; Liu Y; Chen H; Wang Z; Cui Y; Wang L; Ma P; Zhang L Molecules; 2023 Nov; 28(21):. PubMed ID: 37959818 [TBL] [Abstract][Full Text] [Related]
88. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design. Dudhipala N; Veerabrahma K Drug Dev Ind Pharm; 2015; 41(12):1968-77. PubMed ID: 25830370 [TBL] [Abstract][Full Text] [Related]
89. PEGylated solid lipid nanoparticles functionalized by aptamer for targeted delivery of docetaxel in mice bearing C26 tumor. Shakib Z; Mahmoudi A; Moosavian SA; Malaekeh-Nikouei B Drug Dev Ind Pharm; 2022 Feb; 48(2):69-78. PubMed ID: 35758194 [TBL] [Abstract][Full Text] [Related]
90. Characterization and evaluation of metformin-loaded solid lipid nanoparticles for celluar and mitochondrial uptake. Xu Q; Zhu T; Yi C; Shen Q Drug Dev Ind Pharm; 2016 May; 42(5):701-706. PubMed ID: 26258801 [TBL] [Abstract][Full Text] [Related]
91. Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability. Dora CP; Trotta F; Kushwah V; Devasari N; Singh C; Suresh S; Jain S Carbohydr Polym; 2016 Feb; 137():339-349. PubMed ID: 26686138 [TBL] [Abstract][Full Text] [Related]
92. Formulation of acyclovir-loaded solid lipid nanoparticles: design, optimization, and El-Gizawy SA; El-Maghraby GM; Hedaya AA Pharm Dev Technol; 2019 Dec; 24(10):1287-1298. PubMed ID: 31507232 [TBL] [Abstract][Full Text] [Related]
93. Encapsulated Oxovanadium(IV) and Dioxovanadium(V) Complexes into Solid Lipid Nanoparticles Increase Cytotoxicity Against MDA-MB-231 Cell Line. Kostrzewa T; Nowak I; Feliczak-Guzik A; Drzeżdżon J; Jacewicz D; Górska-Ponikowska M; Kuban-Jankowska A Int J Nanomedicine; 2023; 18():2507-2523. PubMed ID: 37197025 [TBL] [Abstract][Full Text] [Related]
94. Enhanced Oral Absorption of All-trans Retinoic Acid upon Encapsulation in Solid Lipid Nanoparticles. Kumar M; Sharma G; Singla D; Singh S; Kakkar V; Gulati JS; Kaur IP Pharm Nanotechnol; 2020; 8(6):495-510. PubMed ID: 33115399 [TBL] [Abstract][Full Text] [Related]
95. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo. Zheng G; Zheng M; Yang B; Fu H; Li Y Biomed Pharmacother; 2019 Aug; 116():109006. PubMed ID: 31152925 [TBL] [Abstract][Full Text] [Related]
96. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles. Jiang S; Gong X; Zhao X; Zu Y Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890 [TBL] [Abstract][Full Text] [Related]
97. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables. Rathod VR; Shah DA; Dave RH Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896 [TBL] [Abstract][Full Text] [Related]
98. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization. Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672 [TBL] [Abstract][Full Text] [Related]